Though we did not find their associations with preclinical AD susceptibility and CSF AD core biomarkers (p > 0.05), they showed significant associations with methylation levels of BIN1 promoter (p < 0.0001) (Additional file 7). This evidence concerns the gene BIN1 and Alzheimer disease.